Purpura Therapy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031
Description
NGS Target Enrichment Probe Market Trends and Forecast
The future of the global ngs target enrichment probe market looks promising with opportunities in the bioscience company, universities and research institutes, and other markets. The global ngs target enrichment probe market is expected to grow with a CAGR of 17.1% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine and precision genetic testing. and advancements in genomic research driving adoption of targeted sequencing technologies..
Lucintel forecasts that, within the type category, chip probes is expected to witness higher growth over the forecast period.
Within the application category, bioscience companies is expected to witness the higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the NGS Target Enrichment Probe Market
The global NGS target enrichment probe market is evolving with several emerging trends that reflect advancements in genomic research and technology. These trends are helping to meet the growing demand for faster, more accurate, and cost-effective sequencing solutions across various applications, from clinical diagnostics to research in genomics and personalized medicine.
Recent Developments in the NGS Target Enrichment Probe Market
Recent developments in the NGS target enrichment probe market reflect the rapid advancements in genomic research and clinical diagnostics. Innovations in probe chemistry, design, and technology are enhancing the performance of NGS, driving demand across various industries, including oncology, infectious disease research, and genetic testing.
Strategic Growth Opportunities in the NGS Target Enrichment Probe Market
The global NGS target enrichment probe market presents significant growth opportunities, particularly in clinical diagnostics, genomics research, and personalized medicine. As technology advances, companies are developing new strategies to address the growing demand for precise, efficient, and cost-effective sequencing solutions across a variety of applications.
NGS Target Enrichment Probe Market Driver and Challenges
The global NGS target enrichment probe market is influenced by several drivers and challenges that impact the growth and adoption of genomic technologies. These include technological advancements, regulatory factors, and the growing demand for precision medicine, alongside challenges related to cost, scalability, and regulatory compliance.
The factors responsible for driving the Global NGS Target Enrichment Probe market include:
1. Technological Advancements in NGS: The continuous improvements in NGS technology, including higher throughput and greater accuracy, are driving the demand for efficient target enrichment probes. These advancements help make sequencing more accessible and cost-effective across various clinical and research applications.
2. Rising Demand for Precision Medicine: As the field of personalized medicine expands, the need for targeted sequencing and enrichment probes to identify genetic mutations for individualized treatments grows. This demand is pushing innovations in the probe market to support the precise treatment of genetic conditions and cancer.
3. Increase in Cancer Genomics Research: The growing focus on cancer research and personalized oncology treatments is fueling demand for NGS probes. Cancer-specific enrichment probes are essential for accurate detection of genetic mutations and driver genes, contributing to better diagnostic and therapeutic outcomes.
4. Expanding Applications in Genetic Disease Testing: The increasing focus on genetic disease screening and diagnosis is driving the use of NGS target enrichment probes. These probes help identify mutations related to rare genetic diseases, accelerating diagnosis and treatment.
5. Regulatory Support for Genomic Testing: Governments and healthcare organizations are increasingly supporting the use of genomic technologies for diagnostics, which is driving market growth. Regulatory approvals for NGS-based tests are opening new opportunities for enrichment probes in clinical applications.
Challenges in the Global NGS Target Enrichment Probe market are:
1. High Cost of NGS Technologies: Despite technological advancements, the high cost of NGS platforms and enrichment probes remains a significant barrier to widespread adoption, particularly in low- and middle-income countries.
2. Complex Regulatory Landscape: Regulatory hurdles, such as the approval processes for genomic testing kits and probes, can slow market growth. Different countries have varying standards, making it challenging for companies to meet international compliance requirements.
3. Scalability and Supply Chain Issues: The growing demand for NGS technology presents challenges in scaling production of high-quality enrichment probes. Ensuring a stable supply chain, particularly for raw materials and manufacturing capacity, remains a key challenge for the industry.
The drivers of technological advancements, rising demand for precision medicine, and expanding applications in cancer and genetic disease testing are shaping the NGS target enrichment probe market. However, challenges related to cost, regulatory hurdles, and scalability must be addressed for sustained market growth.
List of NGS Target Enrichment Probe Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ngs target enrichment probe companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ngs target enrichment probe companies profiled in this report include-
The study includes a forecast for the global ngs target enrichment probe market by type, application, and region.
NGS Target Enrichment Probe Market by Type [Value from 2019 to 2031]:
The global NGS (Next-Generation Sequencing) target enrichment probe market is evolving rapidly, with significant developments in countries like the United States, China, Germany, India, and Japan. These nations are leading advancements in genomic research, particularly in areas like precision medicine, cancer genomics, and personalized healthcare. The increasing demand for more efficient, accurate, and cost-effective solutions for targeted sequencing is driving growth in the NGS target enrichment probe market.
Market Size Estimates: Ngs target enrichment probe market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Ngs target enrichment probe market size by type, application, and region in terms of value ($B).
Regional Analysis: Ngs target enrichment probe market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the ngs target enrichment probe market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ngs target enrichment probe market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the ngs target enrichment probe market by type (single probe and chip probe), application (bioscience company, universities and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.
The future of the global ngs target enrichment probe market looks promising with opportunities in the bioscience company, universities and research institutes, and other markets. The global ngs target enrichment probe market is expected to grow with a CAGR of 17.1% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine and precision genetic testing. and advancements in genomic research driving adoption of targeted sequencing technologies..
Lucintel forecasts that, within the type category, chip probes is expected to witness higher growth over the forecast period.
Within the application category, bioscience companies is expected to witness the higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the NGS Target Enrichment Probe Market
The global NGS target enrichment probe market is evolving with several emerging trends that reflect advancements in genomic research and technology. These trends are helping to meet the growing demand for faster, more accurate, and cost-effective sequencing solutions across various applications, from clinical diagnostics to research in genomics and personalized medicine.
- Rise in Personalized Medicine: As precision medicine grows in popularity, the demand for targeted enrichment probes is increasing. These probes allow for more accurate sequencing of genes associated with specific diseases, enabling personalized treatment strategies for cancer, genetic disorders, and other conditions. This trend is pushing the need for highly specific and efficient NGS probes.
- Technological Advancements in Probe Design: Significant improvements in probe design and chemistry are enhancing the performance of NGS target enrichment. New techniques for better probe hybridization and amplification are leading to higher sensitivity, accuracy, and coverage in genomic sequencing. This is contributing to faster and more cost-effective sequencing, improving the overall efficiency of NGS workflows.
- Increased Focus on Oncology Applications: Cancer genomics is one of the major drivers for the demand for NGS target enrichment probes. With increasing research into cancer's genetic underpinnings, there is a growing need for probes designed to specifically target oncogenes, tumor suppressor genes, and mutations linked to cancer. This focus is pushing the development of probes tailored for various cancer types.
- Integration with Liquid Biopsy: The integration of NGS target enrichment probes with liquid biopsy technologies is revolutionizing cancer diagnosis and monitoring. Liquid biopsy allows for non-invasive sampling of tumor DNA from blood, and the use of enrichment probes in this process helps detect genetic mutations, offering significant advantages in early cancer detection and monitoring.
- Growth in Infectious Disease Research: The increasing prevalence of infectious diseases, especially viral infections like COVID-19, is driving the use of NGS for pathogen detection. Target enrichment probes are being developed to specifically enrich viral genomes, enabling faster and more accurate detection of infections, mutations, and viral load, thus aiding global public health efforts.
Recent Developments in the NGS Target Enrichment Probe Market
Recent developments in the NGS target enrichment probe market reflect the rapid advancements in genomic research and clinical diagnostics. Innovations in probe chemistry, design, and technology are enhancing the performance of NGS, driving demand across various industries, including oncology, infectious disease research, and genetic testing.
- Improved Probe Performance: Companies have introduced next-generation probes that offer improved sensitivity, specificity, and coverage in NGS workflows. These developments are aimed at providing more accurate sequencing results, particularly in complex genomic regions, leading to better diagnostic capabilities for genetic diseases and cancer.
- Commercialization of Cancer-specific Enrichment Panels: The launch of cancer-specific enrichment panels has accelerated the application of NGS in oncology. These panels target key cancer genes and mutations, enabling precise detection of genetic alterations that drive tumor growth, thus improving early diagnosis and treatment strategies.
- Expansion of Liquid Biopsy Solutions: There has been a surge in the development of NGS probes tailored for liquid biopsy applications. Liquid biopsy offers a non-invasive method for monitoring cancer patients, and the integration of NGS with target enrichment probes enhances the detection of mutations and tumor profiling from blood samples.
- Technological Innovations in Probe Chemistry: Advances in probe chemistry, such as the use of synthetic biology and CRISPR-based methods, have improved the efficiency of enrichment reactions. These innovations are leading to faster turnaround times and more cost-effective sequencing, which is crucial for clinical and research applications.
- Regulatory Approvals and Commercialization in Emerging Markets: Companies have achieved regulatory approvals for their NGS probes in emerging markets such as India and China. This is facilitating the wider adoption of NGS technologies in clinical diagnostics, particularly in genetic screening, infectious disease detection, and oncology.
Strategic Growth Opportunities in the NGS Target Enrichment Probe Market
The global NGS target enrichment probe market presents significant growth opportunities, particularly in clinical diagnostics, genomics research, and personalized medicine. As technology advances, companies are developing new strategies to address the growing demand for precise, efficient, and cost-effective sequencing solutions across a variety of applications.
- Opportunities in Cancer Genomics: Cancer genomics represents a major growth opportunity for NGS target enrichment probes. With increasing research into cancer-specific mutations and the growing need for personalized treatment, there is substantial demand for enrichment probes designed to target cancer-related genes, mutations, and biomarkers.
- Expanding Applications in Rare Disease Diagnostics: Rare genetic diseases require highly specialized diagnostic tools. NGS target enrichment probes tailored for rare disease genes present a growth opportunity, enabling faster and more accurate diagnosis and treatment options, especially in underserved populations.
- Personalized Medicine Market Growth: As personalized medicine becomes more mainstream, the demand for NGS probes to identify genetic variations that influence treatment response is increasing. Target enrichment probes play a critical role in tailoring treatments for patients, particularly in oncology and pharmacogenomics.
- Growth in Infectious Disease Surveillance: The need for rapid and accurate pathogen detection, particularly for emerging diseases, is creating growth opportunities for NGS target enrichment probes in infectious disease diagnostics. Enrichment probes for viral and bacterial pathogens are essential for genomic surveillance, helping in early detection and outbreak management.
- Emerging Markets Adoption: As NGS technology becomes more accessible, particularly in emerging markets like India, China, and Latin America, there is a growing demand for affordable enrichment probes. This presents opportunities for companies to expand their offerings in these regions, where the demand for genomic diagnostics is rising.
NGS Target Enrichment Probe Market Driver and Challenges
The global NGS target enrichment probe market is influenced by several drivers and challenges that impact the growth and adoption of genomic technologies. These include technological advancements, regulatory factors, and the growing demand for precision medicine, alongside challenges related to cost, scalability, and regulatory compliance.
The factors responsible for driving the Global NGS Target Enrichment Probe market include:
1. Technological Advancements in NGS: The continuous improvements in NGS technology, including higher throughput and greater accuracy, are driving the demand for efficient target enrichment probes. These advancements help make sequencing more accessible and cost-effective across various clinical and research applications.
2. Rising Demand for Precision Medicine: As the field of personalized medicine expands, the need for targeted sequencing and enrichment probes to identify genetic mutations for individualized treatments grows. This demand is pushing innovations in the probe market to support the precise treatment of genetic conditions and cancer.
3. Increase in Cancer Genomics Research: The growing focus on cancer research and personalized oncology treatments is fueling demand for NGS probes. Cancer-specific enrichment probes are essential for accurate detection of genetic mutations and driver genes, contributing to better diagnostic and therapeutic outcomes.
4. Expanding Applications in Genetic Disease Testing: The increasing focus on genetic disease screening and diagnosis is driving the use of NGS target enrichment probes. These probes help identify mutations related to rare genetic diseases, accelerating diagnosis and treatment.
5. Regulatory Support for Genomic Testing: Governments and healthcare organizations are increasingly supporting the use of genomic technologies for diagnostics, which is driving market growth. Regulatory approvals for NGS-based tests are opening new opportunities for enrichment probes in clinical applications.
Challenges in the Global NGS Target Enrichment Probe market are:
1. High Cost of NGS Technologies: Despite technological advancements, the high cost of NGS platforms and enrichment probes remains a significant barrier to widespread adoption, particularly in low- and middle-income countries.
2. Complex Regulatory Landscape: Regulatory hurdles, such as the approval processes for genomic testing kits and probes, can slow market growth. Different countries have varying standards, making it challenging for companies to meet international compliance requirements.
3. Scalability and Supply Chain Issues: The growing demand for NGS technology presents challenges in scaling production of high-quality enrichment probes. Ensuring a stable supply chain, particularly for raw materials and manufacturing capacity, remains a key challenge for the industry.
The drivers of technological advancements, rising demand for precision medicine, and expanding applications in cancer and genetic disease testing are shaping the NGS target enrichment probe market. However, challenges related to cost, regulatory hurdles, and scalability must be addressed for sustained market growth.
List of NGS Target Enrichment Probe Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ngs target enrichment probe companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ngs target enrichment probe companies profiled in this report include-
- Agilent
- Nanjing Vazyme Biotech
- COBIOER
- iGeneTech
- Shanghai Biotechnology
The study includes a forecast for the global ngs target enrichment probe market by type, application, and region.
NGS Target Enrichment Probe Market by Type [Value from 2019 to 2031]:
- Single Probe
- Chip Probe
- Bioscience Company
- Universities And Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
The global NGS (Next-Generation Sequencing) target enrichment probe market is evolving rapidly, with significant developments in countries like the United States, China, Germany, India, and Japan. These nations are leading advancements in genomic research, particularly in areas like precision medicine, cancer genomics, and personalized healthcare. The increasing demand for more efficient, accurate, and cost-effective solutions for targeted sequencing is driving growth in the NGS target enrichment probe market.
- United States: In the United States, the NGS target enrichment probe market is witnessing substantial growth driven by innovations in genomic research and personalized medicine. Companies like Illumina and Thermo Fisher are expanding their offerings of targeted enrichment solutions for various applications, including cancer genomics, genetic disorders, and microbiome research. There is also a strong focus on improving the efficiency of enrichment protocols, which has led to the development of high-throughput, accurate, and cost-effective probes for NGS.
- China: China is rapidly becoming a key player in the NGS target enrichment probe market, with substantial government investments in genomics and biotechnology. The Chinese government is actively promoting genomics-based healthcare solutions, including precision medicine and genomic screening. Local companies such as BGI are advancing NGS technologies, including the development of high-quality target enrichment probes for a variety of applications, particularly in population genomics and cancer research. This growth is being fueled by an increasing number of sequencing centers and partnerships with international organizations.
- Germany: Germany is at the forefront of NGS target enrichment probe development, with strong support from both academic and private sectors. The country is a leader in medical research, particularly in genomics, and companies like Biozym and Qiagen are playing a significant role in the NGS probe market. Research collaborations and clinical applications are driving demand for specialized enrichment probes, particularly for oncology and rare genetic diseases. Moreover, Germany’s focus on precision medicine and personalized healthcare has spurred the development of advanced sequencing probes.
- India: India’s NGS target enrichment probe market is gaining traction, particularly with the growing emphasis on affordable genomic research and diagnostics. With rising healthcare costs and a large patient population, India is focusing on making precision medicine and genomic testing more accessible. Local companies, alongside global leaders like Illumina, are developing cost-effective NGS target enrichment probes tailored to the Indian market. The application of these probes in cancer research, infectious diseases, and genetic disorders is accelerating, supported by increasing government and private-sector investments in genomics.
- Japan: Japan has been making significant strides in the NGS target enrichment probe market, driven by strong research and development (R&D) capabilities and a high level of expertise in genomic medicine. Companies like Takara Bio and Sysmex are pioneering the development of advanced target enrichment solutions for NGS applications. Japan’s focus on healthcare innovation, especially in oncology, rare diseases, and genetic disorders, has led to a growing demand for high-quality, efficient enrichment probes to enhance the accuracy of sequencing technologies.
Market Size Estimates: Ngs target enrichment probe market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Ngs target enrichment probe market size by type, application, and region in terms of value ($B).
Regional Analysis: Ngs target enrichment probe market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the ngs target enrichment probe market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ngs target enrichment probe market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the ngs target enrichment probe market by type (single probe and chip probe), application (bioscience company, universities and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.
Table of Contents
150 Pages
- 1. Executive Summary
- 2. Market Overview
- 2.1 Background and Classifications
- 2.2 Supply Chain
- 3. Market Trends & Forecast Analysis
- 3.1 Global Purpura Therapy Drug Market Trends and Forecast
- 3.2 Industry Drivers and Challenges
- 3.3 PESTLE Analysis
- 3.4 Patent Analysis
- 3.5 Regulatory Environment
- 4. Global Purpura Therapy Drug Market by Type
- 4.1 Overview
- 4.2 Attractiveness Analysis by Type
- 4.3 Allergic Purpura: Trends and Forecast (2019-2031)
- 4.4 Thrombocytopenic Purpura: Trends and Forecast (2019-2031)
- 5. Global Purpura Therapy Drug Market by Application
- 5.1 Overview
- 5.2 Attractiveness Analysis by Application
- 5.3 Hospital Use: Trends and Forecast (2019-2031)
- 5.4 Clinic Use: Trends and Forecast (2019-2031)
- 5.5 Household: Trends and Forecast (2019-2031)
- 5.6 Others: Trends and Forecast (2019-2031)
- 6. Regional Analysis
- 6.1 Overview
- 6.2 Global Purpura Therapy Drug Market by Region
- 7. North American Purpura Therapy Drug Market
- 7.1 Overview
- 7.2 North American Purpura Therapy Drug Market by type
- 7.3 North American Purpura Therapy Drug Market by application
- 7.4 United States Purpura Therapy Drug Market
- 7.5 Mexican Purpura Therapy Drug Market
- 7.6 Canadian Purpura Therapy Drug Market
- 8. European Purpura Therapy Drug Market
- 8.1 Overview
- 8.2 European Purpura Therapy Drug Market by type
- 8.3 European Purpura Therapy Drug Market by application
- 8.4 German Purpura Therapy Drug Market
- 8.5 French Purpura Therapy Drug Market
- 8.6 Spanish Purpura Therapy Drug Market
- 8.7 Italian Purpura Therapy Drug Market
- 8.8 United Kingdom Purpura Therapy Drug Market
- 9. APAC Purpura Therapy Drug Market
- 9.1 Overview
- 9.2 APAC Purpura Therapy Drug Market by type
- 9.3 APAC Purpura Therapy Drug Market by application
- 9.4 Japanese Purpura Therapy Drug Market
- 9.5 Indian Purpura Therapy Drug Market
- 9.6 Chinese Purpura Therapy Drug Market
- 9.7 South Korean Purpura Therapy Drug Market
- 9.8 Indonesian Purpura Therapy Drug Market
- 10. ROW Purpura Therapy Drug Market
- 10.1 Overview
- 10.2 ROW Purpura Therapy Drug Market by type
- 10.3 ROW Purpura Therapy Drug Market by application
- 10.4 Middle Eastern Purpura Therapy Drug Market
- 10.5 South American Purpura Therapy Drug Market
- 10.6 African Purpura Therapy Drug Market
- 11. Competitor Analysis
- 11.1 Product Portfolio Analysis
- 11.2 Operational Integration
- 11.3 Porter’s Five Forces Analysis
- • Competitive Rivalry
- • Bargaining Power of Buyers
- • Bargaining Power of Suppliers
- • Threat of Substitutes
- • Threat of New Entrants
- 11.4 Market Share Analysis
- 12. Opportunities & Strategic Analysis
- 12.1 Value Chain Analysis
- 12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
- 12.3 Emerging Trends in the Global Purpura Therapy Drug Market
- 12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures
- 13. Company Profiles of the Leading Players Across the Value Chain
- 13.1 Competitive Analysis
- 13.2 Bristol-Myers Squibb Company
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.3 Pfizer Inc
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.4 GlaxoSmithKline Plc
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.5 Novartis AG
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.6 Hovione
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.7 Sanofi Winthrop Industrie S.A.
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.8 Hoffman-L Roche
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.9 Amgen Inc
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.10 Grifols Biologicals Inc
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 13.11 Ablynx NV
- • Company Overview
- • Purpura Therapy Drug Business Overview
- • New Product Development
- • Merger, Acquisition, and Collaboration
- • Certification and Licensing
- 14. Appendix
- 14.1 List of Figures
- 14.2 List of Tables
- 14.3 Research Methodology
- 14.4 Disclaimer
- 14.5 Copyright
- 14.6 Abbreviations and Technical Units
- 14.7 About Us
- 14.8 Contact Us
- List of Figures
- Chapter 1
- Figure 1.1: Trends and Forecast for the Global Purpura Therapy Drug Market
- Chapter 2
- Figure 2.1: Usage of Purpura Therapy Drug Market
- Figure 2.2: Classification of the Global Purpura Therapy Drug Market
- Figure 2.3: Supply Chain of the Global Purpura Therapy Drug Market
- Chapter 3
- Figure 3.1: Driver and Challenges of the Purpura Therapy Drug Market
- Figure 3.2: PESTLE Analysis
- Figure 3.3: Patent Analysis
- Figure 3.4: Regulatory Environment
- Chapter 4
- Figure 4.1: Global Purpura Therapy Drug Market by Type in 2019, 2024, and 2031
- Figure 4.2: Trends of the Global Purpura Therapy Drug Market ($B) by Type
- Figure 4.3: Forecast for the Global Purpura Therapy Drug Market ($B) by Type
- Figure 4.4: Trends and Forecast for Allergic Purpura in the Global Purpura Therapy Drug Market (2019-2031)
- Figure 4.5: Trends and Forecast for Thrombocytopenic Purpura in the Global Purpura Therapy Drug Market (2019-2031)
- Chapter 5
- Figure 5.1: Global Purpura Therapy Drug Market by Application in 2019, 2024, and 2031
- Figure 5.2: Trends of the Global Purpura Therapy Drug Market ($B) by Application
- Figure 5.3: Forecast for the Global Purpura Therapy Drug Market ($B) by Application
- Figure 5.4: Trends and Forecast for Hospital Use in the Global Purpura Therapy Drug Market (2019-2031)
- Figure 5.5: Trends and Forecast for Clinic Use in the Global Purpura Therapy Drug Market (2019-2031)
- Figure 5.6: Trends and Forecast for Household in the Global Purpura Therapy Drug Market (2019-2031)
- Figure 5.7: Trends and Forecast for Others in the Global Purpura Therapy Drug Market (2019-2031)
- Chapter 6
- Figure 6.1: Trends of the Global Purpura Therapy Drug Market ($B) by Region (2019-2024)
- Figure 6.2: Forecast for the Global Purpura Therapy Drug Market ($B) by Region (2025-2031)
- Chapter 7
- Figure 7.1: North American Purpura Therapy Drug Market by type in 2019, 2024, and 2031
- Figure 7.2: Trends of the North American Purpura Therapy Drug Market ($B) by type (2019-2024)
- Figure 7.3: Forecast for the North American Purpura Therapy Drug Market ($B) by type (2025-2031)
- Figure 7.4: North American Purpura Therapy Drug Market by application in 2019, 2024, and 2031
- Figure 7.5: Trends of the North American Purpura Therapy Drug Market ($B) by application (2019-2024)
- Figure 7.6: Forecast for the North American Purpura Therapy Drug Market ($B) by application (2025-2031)
- Figure 7.7: Trends and Forecast for the United States Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 7.8: Trends and Forecast for the Mexican Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 7.9: Trends and Forecast for the Canadian Purpura Therapy Drug Market ($B) (2019-2031)
- Chapter 8
- Figure 8.1: European Purpura Therapy Drug Market by type in 2019, 2024, and 2031
- Figure 8.2: Trends of the European Purpura Therapy Drug Market ($B) by type (2019-2024)
- Figure 8.3: Forecast for the European Purpura Therapy Drug Market ($B) by type (2025-2031)
- Figure 8.4: European Purpura Therapy Drug Market by application in 2019, 2024, and 2031
- Figure 8.5: Trends of the European Purpura Therapy Drug Market ($B) by application (2019-2024)
- Figure 8.6: Forecast for the European Purpura Therapy Drug Market ($B) by application (2025-2031)
- Figure 8.7: Trends and Forecast for the German Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 8.8: Trends and Forecast for the French Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 8.9: Trends and Forecast for the Spanish Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 8.10: Trends and Forecast for the Italian Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 8.11: Trends and Forecast for the United Kingdom Purpura Therapy Drug Market ($B) (2019-2031)
- Chapter 9
- Figure 9.1: APAC Purpura Therapy Drug Market by type in 2019, 2024, and 2031
- Figure 9.2: Trends of the APAC Purpura Therapy Drug Market ($B) by type (2019-2024)
- Figure 9.3: Forecast for the APAC Purpura Therapy Drug Market ($B) by type (2025-2031)
- Figure 9.4: APAC Purpura Therapy Drug Market by application in 2019, 2024, and 2031
- Figure 9.5: Trends of the APAC Purpura Therapy Drug Market ($B) by application (2019-2024)
- Figure 9.6: Forecast for the APAC Purpura Therapy Drug Market ($B) by application (2025-2031)
- Figure 9.7: Trends and Forecast for the Japanese Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 9.8: Trends and Forecast for the Indian Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 9.9: Trends and Forecast for the Chinese Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 9.10: Trends and Forecast for the South Korean Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 9.11: Trends and Forecast for the Indonesian Purpura Therapy Drug Market ($B) (2019-2031)
- Chapter 10
- Figure 10.1: ROW Purpura Therapy Drug Market by type in 2019, 2024, and 2031
- Figure 10.2: Trends of the ROW Purpura Therapy Drug Market ($B) by type (2019-2024)
- Figure 10.3: Forecast for the ROW Purpura Therapy Drug Market ($B) by type (2025-2031)
- Figure 10.4: ROW Purpura Therapy Drug Market by application in 2019, 2024, and 2031
- Figure 10.5: Trends of the ROW Purpura Therapy Drug Market ($B) by application (2019-2024)
- Figure 10.6: Forecast for the ROW Purpura Therapy Drug Market ($B) by application (2025-2031)
- Figure 10.7: Trends and Forecast for the Middle Eastern Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 10.8: Trends and Forecast for the South American Purpura Therapy Drug Market ($B) (2019-2031)
- Figure 10.9: Trends and Forecast for the African Purpura Therapy Drug Market ($B) (2019-2031)
- Chapter 11
- Figure 11.1: Porter’s Five Forces Analysis of the Global Purpura Therapy Drug Market
- Figure 11.2: Market Share (%) of Top Players in the Global Purpura Therapy Drug Market (2024)
- Chapter 12
- Figure 12.1: Growth Opportunities for the Global Purpura Therapy Drug Market by Type
- Figure 12.2: Growth Opportunities for the Global Purpura Therapy Drug Market by Application
- Figure 12.3: Growth Opportunities for the Global Purpura Therapy Drug Market by Region
- Figure 12.4: Emerging Trends in the Global Purpura Therapy Drug Market
- List of Tables
- Chapter 1
- Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Purpura Therapy Drug Market by Type and Application
- Table 1.2: Attractiveness Analysis for the Purpura Therapy Drug Market by Region
- Table 1.3: Global Purpura Therapy Drug Market Parameters and Attributes
- Chapter 3
- Table 3.1: Trends of the Global Purpura Therapy Drug Market (2019-2024)
- Table 3.2: Forecast for the Global Purpura Therapy Drug Market (2025-2031)
- Chapter 4
- Table 4.1: Attractiveness Analysis for the Global Purpura Therapy Drug Market by Type
- Table 4.2: Market Size and CAGR of Various Type in the Global Purpura Therapy Drug Market (2019-2024)
- Table 4.3: Market Size and CAGR of Various Type in the Global Purpura Therapy Drug Market (2025-2031)
- Table 4.4: Trends of Allergic Purpura in the Global Purpura Therapy Drug Market (2019-2024)
- Table 4.5: Forecast for Allergic Purpura in the Global Purpura Therapy Drug Market (2025-2031)
- Table 4.6: Trends of Thrombocytopenic Purpura in the Global Purpura Therapy Drug Market (2019-2024)
- Table 4.7: Forecast for Thrombocytopenic Purpura in the Global Purpura Therapy Drug Market (2025-2031)
- Chapter 5
- Table 5.1: Attractiveness Analysis for the Global Purpura Therapy Drug Market by Application
- Table 5.2: Market Size and CAGR of Various Application in the Global Purpura Therapy Drug Market (2019-2024)
- Table 5.3: Market Size and CAGR of Various Application in the Global Purpura Therapy Drug Market (2025-2031)
- Table 5.4: Trends of Hospital Use in the Global Purpura Therapy Drug Market (2019-2024)
- Table 5.5: Forecast for Hospital Use in the Global Purpura Therapy Drug Market (2025-2031)
- Table 5.6: Trends of Clinic Use in the Global Purpura Therapy Drug Market (2019-2024)
- Table 5.7: Forecast for Clinic Use in the Global Purpura Therapy Drug Market (2025-2031)
- Table 5.8: Trends of Household in the Global Purpura Therapy Drug Market (2019-2024)
- Table 5.9: Forecast for Household in the Global Purpura Therapy Drug Market (2025-2031)
- Table 5.10: Trends of Others in the Global Purpura Therapy Drug Market (2019-2024)
- Table 5.11: Forecast for Others in the Global Purpura Therapy Drug Market (2025-2031)
- Chapter 6
- Table 6.1: Market Size and CAGR of Various Regions in the Global Purpura Therapy Drug Market (2019-2024)
- Table 6.2: Market Size and CAGR of Various Regions in the Global Purpura Therapy Drug Market (2025-2031)
- Chapter 7
- Table 7.1: Trends of the North American Purpura Therapy Drug Market (2019-2024)
- Table 7.2: Forecast for the North American Purpura Therapy Drug Market (2025-2031)
- Table 7.3: Market Size and CAGR of Various type in the North American Purpura Therapy Drug Market (2019-2024)
- Table 7.4: Market Size and CAGR of Various type in the North American Purpura Therapy Drug Market (2025-2031)
- Table 7.5: Market Size and CAGR of Various application in the North American Purpura Therapy Drug Market (2019-2024)
- Table 7.6: Market Size and CAGR of Various application in the North American Purpura Therapy Drug Market (2025-2031)
- Table 7.7: Trends and Forecast for the United States Purpura Therapy Drug Market (2019-2031)
- Table 7.8: Trends and Forecast for the Mexican Purpura Therapy Drug Market (2019-2031)
- Table 7.9: Trends and Forecast for the Canadian Purpura Therapy Drug Market (2019-2031)
- Chapter 8
- Table 8.1: Trends of the European Purpura Therapy Drug Market (2019-2024)
- Table 8.2: Forecast for the European Purpura Therapy Drug Market (2025-2031)
- Table 8.3: Market Size and CAGR of Various type in the European Purpura Therapy Drug Market (2019-2024)
- Table 8.4: Market Size and CAGR of Various type in the European Purpura Therapy Drug Market (2025-2031)
- Table 8.5: Market Size and CAGR of Various application in the European Purpura Therapy Drug Market (2019-2024)
- Table 8.6: Market Size and CAGR of Various application in the European Purpura Therapy Drug Market (2025-2031)
- Table 8.7: Trends and Forecast for the German Purpura Therapy Drug Market (2019-2031)
- Table 8.8: Trends and Forecast for the French Purpura Therapy Drug Market (2019-2031)
- Table 8.9: Trends and Forecast for the Spanish Purpura Therapy Drug Market (2019-2031)
- Table 8.10: Trends and Forecast for the Italian Purpura Therapy Drug Market (2019-2031)
- Table 8.11: Trends and Forecast for the United Kingdom Purpura Therapy Drug Market (2019-2031)
- Chapter 9
- Table 9.1: Trends of the APAC Purpura Therapy Drug Market (2019-2024)
- Table 9.2: Forecast for the APAC Purpura Therapy Drug Market (2025-2031)
- Table 9.3: Market Size and CAGR of Various type in the APAC Purpura Therapy Drug Market (2019-2024)
- Table 9.4: Market Size and CAGR of Various type in the APAC Purpura Therapy Drug Market (2025-2031)
- Table 9.5: Market Size and CAGR of Various application in the APAC Purpura Therapy Drug Market (2019-2024)
- Table 9.6: Market Size and CAGR of Various application in the APAC Purpura Therapy Drug Market (2025-2031)
- Table 9.7: Trends and Forecast for the Japanese Purpura Therapy Drug Market (2019-2031)
- Table 9.8: Trends and Forecast for the Indian Purpura Therapy Drug Market (2019-2031)
- Table 9.9: Trends and Forecast for the Chinese Purpura Therapy Drug Market (2019-2031)
- Table 9.10: Trends and Forecast for the South Korean Purpura Therapy Drug Market (2019-2031)
- Table 9.11: Trends and Forecast for the Indonesian Purpura Therapy Drug Market (2019-2031)
- Chapter 10
- Table 10.1: Trends of the ROW Purpura Therapy Drug Market (2019-2024)
- Table 10.2: Forecast for the ROW Purpura Therapy Drug Market (2025-2031)
- Table 10.3: Market Size and CAGR of Various type in the ROW Purpura Therapy Drug Market (2019-2024)
- Table 10.4: Market Size and CAGR of Various type in the ROW Purpura Therapy Drug Market (2025-2031)
- Table 10.5: Market Size and CAGR of Various application in the ROW Purpura Therapy Drug Market (2019-2024)
- Table 10.6: Market Size and CAGR of Various application in the ROW Purpura Therapy Drug Market (2025-2031)
- Table 10.7: Trends and Forecast for the Middle Eastern Purpura Therapy Drug Market (2019-2031)
- Table 10.8: Trends and Forecast for the South American Purpura Therapy Drug Market (2019-2031)
- Table 10.9: Trends and Forecast for the African Purpura Therapy Drug Market (2019-2031)
- Chapter 11
- Table 11.1: Product Mapping of Purpura Therapy Drug Suppliers Based on Segments
- Table 11.2: Operational Integration of Purpura Therapy Drug Manufacturers
- Table 11.3: Rankings of Suppliers Based on Purpura Therapy Drug Revenue
- Chapter 12
- Table 12.1: New Product Launches by Major Purpura Therapy Drug Producers (2019-2024)
- Table 12.2: Certification Acquired by Major Competitor in the Global Purpura Therapy Drug Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.